SM
VBIV

Sabby Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Sabby Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-29,205
Closed -$413K – 94
2019
Q3 		$413K Buy
+29,205
New +$612K 0.22% 46

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Sabby Management's VBIV Position: Q4 2019 in Review

Sabby Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2019, closing a stake of 29,205 shares — an estimated $413K sold.

Sabby Management first reported a position in VBIV in Q3 2019 and held it in 1 quarter. The position peaked at $413K in Q3 2019. 75 funds tracked by Wall St. Rank hold VBIV as of Q4 2019.

  • Sabby Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2019 after selling out during the quarter.
  • Sabby Management sold 29,205 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2019, an estimated $413K.
  • Sabby Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 1 quarter.
  • Sabby Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $413K in Q3 2019.
  • 75 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2019.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.